Entasis Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment Conference

Date : 09/03/2019 @ 12:00PM
Source : GlobeNewswire Inc.
Stock : Entasis Therapeutics Holdings Inc (ETTX)
Quote : 4.89  -0.2 (-3.93%) @ 10:59PM

Entasis Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment Conference

Entasis Therapeutics (NASDAQ:ETTX)
Historical Stock Chart

3 Months : From Aug 2019 to Nov 2019

Click Here for more Entasis Therapeutics Charts.

Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced that Dr. Manos Perros, President and Chief Executive Officer of the Company, will present at the H.C. Wainwright 21st Annual Global Investment Conference being held September 8-10, 2019 in New York. 

Details of the presentation are below:

Event:                      H.C. Wainwright 21st Annual Global Investment Conference Date:                        Monday, September 9, 2019Location:                 Lotte New York Palace Hotel Time:                       11:40 – 12:05 PM ET

Additionally, Dr. Perros will hold 1-on-1 investor meetings at the conference. Investors attending the conference who are interested in meeting with Company management should contact their H.C. Wainwright representatives.

About EntasisEntasis is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel antibacterial products to treat serious infections caused by multidrug-resistant Gram-negative bacteria. Entasis’ pathogen-targeted design platform has produced a pipeline of product candidates, including sulbactam-durlobactam (targeting Acinetobacter baumannii infections), zoliflodacin (targeting Neisseria gonorrhoeae), and ETX0282CPDP (targeting Enterobacteriaceae infections). Entasis is also using its platform to develop a novel class of antibiotics, non-β-lactam inhibitors of the penicillin-binding proteins (NBPs) (targeting Gram-negative infections). For more information, visit www.entasistx.com.

Entasis Company Contact     Kyle Dow Entasis Therapeutics (781) 810-0114 kyle.dow@entasistx.com

Investor Relations Contact Tram Bui The Ruth Group (646) 536-7035 tbui@theruthgroup.com

Media ContactKirsten ThomasThe Ruth Group(508) 280-6592kthomas@theruthgroup.com 

Latest ETTX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.